Infective endocarditis and glycopeptides

Journal of Infection

Volumn 37, Issue 2, 1998, Pages 127-135

  Pittet, D ^a   Harding, I ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b Micron Research Limited   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPEPTIDE; POLYPEPTIDE ANTIBIOTIC AGENT; TEICOPLANIN; VANCOMYCIN;

ARTICLE; BACTERIAL ENDOCARDITIS; GRAM POSITIVE BACTERIUM; MORTALITY; NEPHROTOXICITY; RETROSPECTIVE STUDY;

EID: 0031789393     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-4453(98)80166-7     Document Type: Article

References (21)

1. In: Mandell GL, Douglas RG, Bennett JE, eds. Principles and practice of infectious disease, 3rd edn. Churchill Livingstone, 1990.
2. Karchmer AW. Antibiotic therapy of non-enterococcal streptococcal and staphylococcal endocarditis: current regimens and some future considerations. J Antimicrob Chemother 1988; 21(Suppl. C): 91-103.
3. Editorial. Infective endocarditis. Br Med J 1981: 282: 677-678.
4. Working Party of the British Society for Antimicrobial Chemotherapy. Antibiotic treatment of streptococcal, enterococcal, and staphylococcal endocarditis. Heart 1998; 79: 207-210.
5. Roberts KB, Sidlak MJ. Satellite streptococci. A major cause of 'negative' blood cultures in bacterial endocarditis? JAMA 1979; 241: 2293-2294.
6. Watanakunakorn C, Baird IM. Prognostic factors in S. aureus endocarditis and results of therapy with a penicillin and gentamicin. Am J Med Sci 1977; 273: 133-139.
7. Espersen F, Frimodt-Moller N. S. aureus endocarditis: a review of 119 cases. Arch Intern Med 1986; 146: 1118-1121.
8. ESCMID. European guidelines for the clinical evaluation of antiinfective drug products. ESCMID, 1993.
9. Whitener C, Caputo GM, Weitekamp MR, Karchmer AW. Endocarditis due to coagulase-negative staphylococci. Infect Dis Clin North Am 1993; 7: 81-96.
10. Kaye D. Infecting microorganisms. In: Kaye D, ed. Infective endocarditis. Baltimore University Park Press, 1976: 43-54.
11. Karchmer AW, Archer GL, Dismukes WE. S. epidermidis causing prosthetic valve endocarditis: microbiologic and clinical observations as guides to therapy. Ann Intern Med 1983; 98: 447-455.
12. McGivern D, Ispahani P, Banks D. Factors influencing mortality from infective endocarditis in two district general hospitals. Postgrad Med J 1987; 63: 345-349.
13. Working Party of the British Society of Antimicrobial Chemotherapy. Antibiotic treatment of streptococcal and staphylococcal endocarditis. Lancet 1985; ii: 815-817.
14. Wilson WR, Karchmer AW, Dajani AS et al. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. JAMA 1995; 274: 1706-1713.
15. Chambers HE Miller RT, Newman MD. Right-sided S. aureus endocarditis in IVDA: two-week combination therapy. Ann Intern Med 1988; 109: 619-624.
16. Dworldn RJ, Sande MA, Lee BL, Chambers HE Treatment of right-sided S. aureus endocarditis in IVDA with ciprofloxacin and rifampicin. Lancet 1989; ii: 1071-1073.
17. Francioli P, Etienne J, Hoigné R, Thys JP, Gerber A. Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone sodium for 4 weeks. Efficacy and outpatient treatment feasibility. JAMA 1992; 267: 264-267.
18. Kureishi A, Jewesson PJ, Rubinger M et al. Double-blind comparison of teicoplanin versus vancomycin in febrile neutropenic patients receiving concomitant tobramycin and piperacillin: effect on cyclosporin A-associated nephrotoxicity. Antimicrob Agents Chemother 1991; 35: 2246-2252.
19. Sullam PF, Täuber MG. Hackbarth CJ, Sande MA. Therapeutic efficacy of teicoplanin in experimental enterococcal endocarditis. Antimicrob Agents Chemother 1985; 27: 135-136.
20. Smith SR, Cheesbrough J, Spearing R, Davies JM. Randomized prospective study comparing vancomycin with teicoplanin in the treatment of Hickman catheter infections. Antimicrob Agents Chemother 1989; 33: 1193-1197.
21. Gopal V, Bisno AL, Silverblatt FJ. Failure of vancomycin treatment in Staphylococcus aureus endocarditis. In vivo and in vitro observations. JAMA 1976; 236: 1604-1606.